• A tiny biotech's huge bet on a heart pill abandoned by Big Pharma just paid off. Esperion's CEO shares the old-school sales strategy he's planning for the drug

    1 month ago - By Business Insider

    Esperion Therapeutics just got its first heart drug approved in the US, and the CEO told Business Insider the company is pricing the cholesterol-lowering medication at around $10 per day.
    "Our industry was built on once-a-day pills for chronic disease," Esperion CEO Tim Mayleben said in an interview.
    It's an old-school approach that supports blockbuster hopes for Esperion's pill.
    Other companies that have set higher prices for their heart drugs have fallen short in recent years.
    Visit Business Insider's homepage for more stories .
    Esperion Therapeutics just received its first US approval...
    Read more ...

     

  • WeWork's US president - and Adam Neumann's friend - will leave days after the firm's new CEO joins

    WeWork's US president - and Adam Neumann's friend - will leave days after the firm's new CEO joins

    1 month ago - By Business Insider

    Arik Benzino, WeWork's head of US, Canada, and Israel, is leaving, sources told Business Insider.
    His departure comes during the first week on the job for new CEO Sandeep Mathrani.
    Mathrani named a new chief operating officer on Thursday, and more executive shakeups are likely on the way.
    For more WeWork stories,
    Read more ...